Revenue
1.68 million USD
2025 · USD
Exact inputs and evidence
- Revenue: 1675239 USD Source
Annual consolidated revenue for 2025: about USD 1.675M, using the latest reported figures. The previous period, 2024, was about USD 2.214M.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Insider filings have not been processed for this company yet.
Institutional holders (Form 13F) are not yet shown here.
1146117 shares
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-01.
Financial data available through: 2025-09-30.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 2.21 million
–
Current period
USD 1.68 million
–
1675239 − 2213787 = -538548 USD
2213787 USD · 2023-10-01 – 2024-09-30
Inspect prior input Prior source1675239 USD · 2024-10-01 – 2025-09-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 778,382
–
Current period
−USD 2.02 million
–
-2022575 − 778382 = -2800957 USD
778382 USD · 2023-10-01 – 2024-09-30
Inspect prior input Prior source-2022575 USD · 2024-10-01 – 2025-09-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 353,164
–
Current period
−USD 5.52 million
–
-5518850 − -353164 = -5165686 USD
-353164 USD · 2023-10-01 – 2024-09-30
Inspect prior input Prior source-5518850 USD · 2024-10-01 – 2025-09-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2023 2022-10-01 – 2023-09-30 | 582253 | 1809030 Derived | -1226777 | 10443 Derived | -1237220 | -988393 Derived | Source
|
| 2024 2023-10-01 – 2024-09-30 | 2213787 | 1437835 Derived | 775952 | -2430 Derived | 778382 | Unavailable | Source
|
| 2025 2024-10-01 – 2025-09-30 | 1675239 | 3592442 Derived | -1917203 | 105372 Derived | -2022575 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Revenue | 582253 |
|
| 2024 | Revenue | 2213787 |
|
| 2025 | Revenue | 1675239 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | 280.2% |
|
| 2025 | Year over year | -24.3% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Operating margin | -210.7% |
|
| 2024 | Operating margin | 35.1% |
|
| 2025 | Operating margin | -114.4% |
|
| 2023 | Net margin | -212.5% |
|
| 2024 | Net margin | 35.2% |
|
| 2025 | Net margin | -120.7% |
|
| 2023 | Free cash flow margin | -169.8% |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Operating cash flow | -869355 |
|
| 2024 | Operating cash flow | -353164 |
|
| 2025 | Operating cash flow | -5518850 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Free cash flow | -988393 |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023-09-30 | Liabilities / assets | Not reported | No source recorded |
| 2024 | Liabilities / assets | 127.8% |
|
| 2025 | Liabilities / assets | 16.7% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023-09-30 | Current assets / current liabilities | Not reported | No source recorded |
| 2024 | Current assets / current liabilities | 3.02× |
|
| 2025 | Current assets / current liabilities | 7.11× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2023 2022-10-01 – 2023-09-30 | −USD 1.24 million Exact valueExact value: -1237220 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 869,355 Exact valueExact value: -869355 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 119,038 Exact valueExact value: 119038 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 988,393 Calculation and evidence-869355 − 119038 USD Exact free cash flow: -988393 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-10-01 – 2024-09-30 | USD 778,382 Exact valueExact value: 778382 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 353,164 Exact valueExact value: -353164 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2024-10-01 – 2025-09-30 | −USD 2.02 million Exact valueExact value: -2022575 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.52 million Exact valueExact value: -5518850 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
8 filings · 207 latest values · 207 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0002053033, 2053033, PLTS, edgar:2053033
Also known as PLATINUM ANALYTICS CAYMAN LIMITED, Platinum Analytics Cayman Ltd